Nathanielsz James Andrew

CIK 00015549371 companyGLEN IRIS, VICTORIA, C3

SEC Profile

Transactions

Companies

Filings

CIK

0001554937

Recent Transactions

14 trades

Award
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001
2021-08-17+5,928,000→ 5,928,004 total
Award
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001
2021-08-17+2,800,000→ 2,800,000 total
Award
Propanc Biopharma, Inc.$PPCB
Restricted Stock Units
2019-05-14+19,500,000→ 19,500,000 total
Award
Propanc Biopharma, Inc.$PPCB
Restricted Stock Units
2019-05-14+19,500,000→ 19,500,000 total
Award
Propanc Biopharma, Inc.$PPCB
Stock Options (Right to Buy)
2019-05-14+19,500,000→ 19,500,000 total
Award
Propanc Biopharma, Inc.$PPCB
Stock Option (Right to Buy)
2016-04-14+71,500,000→ 71,500,000 total
Other
Propanc Biopharma, Inc.$PPCB
Common Stock, par value $0.001
2015-02-04+33,259,350→ 42,711,111 total
Award
Propanc Biopharma, Inc.$PPCB
Series A Preferred Stock
2014-11-09+500,000→ 500,000 total
Sale
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001 per share
2013-07-05$0.09/sh−55,000→ 9,701,761 total
Sale
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001 per share
2013-01-23$0.20/sh−15,000→ 9,756,761 total
Sale
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001 per share
2012-12-13$0.20/sh−5,500→ 9,771,761 total
Sale
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001 per share
2012-09-14$0.20/sh−5,000→ 9,777,261 total
Sale
Propanc Biopharma, Inc.$PPCB
Common stock, par value $0.001 per share
2012-09-04$0.20/sh−250,000→ 9,782,261 total
Purchase
Propanc Biopharma, Inc.$PPCB
Common Stock
2012-08-23$0.20/sh−250,000→ 9,782,261 total

Companies

Propanc Biopharma, Inc.
Director, Chief Executive Officer, 10% Owner
$PPCB

Recent Filings

Address

1/76 SUMMERHILL ROAD

GLEN IRIS, VICTORIA, C3, 3146

View on SEC.gov